A new method for the synthesis of p-lactams by tributyltin hydride (Bu3SnH)-mediated radical cyclizations of N-ethenyl-a-bromo amides bearing sulfur-substituent(s) a t the terminus of the N-vinylic bond is described. N-[2-(Phenylthio)ethenyll-a-bromoacetamide (1 11, upon treatment with BuaSnH in the presence of azobis(isobutyronitri1e) (AIBN) in boiling toluene, underwent radical cyclization in a 4-exo-trig manner to give p-lactam 13, but in low yield (22%), whereas N-[2,2-bis-(pheny1thio)ethenyll congener 23 cyclized with a high degree of effeciency to give p-lactam 25 and a partially desulfurized lactam 13 in 70% combined yield. The effectiveness of the 4-exo cyclization of 23 can be explained in terms of the high stability of the intermediate of radical 19b. Similar treatment of a-bromobutanamide 24 with Bu3SnH afforded, in 58% yield, p-lactam 26, which was transformed, via aldehyde 31, into the key intermediate 35 for the synthesis of (~0 P s -5 (36). 1,2-Asymmetric induction in radical cyclizations leading to P-lactams was then examined. Cyclization of (2S,3R)-3-acetoxy-2-bromo-N-[2-(phenylthio)ethenyllbutanamide (38) proceeded with no diastereoselectivity to give p-lactams 40a and 40b in approximately equal amounts. However, 2,2-bis-(phenylthio) congener 39 provided (3R,4R)-2-azetidinone 41a and its (3S,4S)-isomer 41b in a ratio of ca. 2:l. Similarly, (2R,3S)-butanamide 47 afforded 48a as a major product. Saponification of 48a followed by partial desulfurization of 49 gave alcohol 50, which was then subjected to Mitsunobu inversion to d o r d 52. This compound was converted into the key intermediate 56 for the synthesis of (+)-thienamycin (58). Reversibility of the radical cyclization leading to the p-lactams is discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.